Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | 0 | uM | 7 | 156.25 | 33.46 | 2.00 | 96.25 | 0.0208 | -0.8425 | |
| SK-BR-3 | Linsitinib | 3.1623 | uM | 9 | 625.00 | 414.82 | 789.00 | 795.25 | 0.9921 | 0.9833 |
| SK-BR-3 | Erlotinib | 0.1 | uM | 7 | 625.00 | 354.63 | 464.00 | 651.00 | 0.7128 | 0.3590 |
| SK-BR-3 | Linsitinib | 1 | uM | 9 | 625.00 | 414.82 | 675.00 | 795.25 | 0.8488 | 0.6796 |
| SK-BR-3 | 0 | uM | 7 | 625.00 | 354.63 | 529.00 | 651.00 | 0.8126 | 0.5783 | |
| SK-BR-3 | 17-AAG | 0.0031623 | uM | 9 | 625.00 | 414.82 | 834.00 | 795.25 | 1.0487 | 1.1040 |
| SK-BR-3 | 0 | uM | 7 | 156.25 | 33.46 | 4.00 | 96.25 | 0.0416 | -0.7518 | |
| SK-BR-3 | 17-AAG | 0.001 | uM | 9 | 625.00 | 414.82 | 792.00 | 795.25 | 0.9959 | 0.9913 |
| SK-BR-3 | Lapatinib | 3.1623 | uM | 7 | 312.50 | 169.63 | 230.00 | 280.00 | 0.8214 | 0.5236 |
| SK-BR-3 | 0 | uM | 9 | 625.00 | 414.82 | 860.00 | 795.25 | 1.0814 | 1.1739 | |
| SK-BR-3 | Erlotinib | 0.1 | uM | 7 | 312.50 | 169.63 | 387.00 | 280.00 | 1.3821 | 2.1290 |
| SK-BR-3 | 0 | uM | 9 | 625.00 | 414.82 | 727.00 | 795.25 | 0.9142 | 0.8177 | |
| SK-BR-3 | 0 | uM | 7 | 156.25 | 33.46 | 2.00 | 96.25 | 0.0208 | -0.8425 | |
| SK-BR-3 | Linsitinib | 19.9526 | uM | 9 | 625.00 | 414.82 | 466.00 | 795.25 | 0.5860 | 0.1319 |
| SK-BR-3 | 0 | uM | 7 | 1250.00 | 859.67 | 1676.00 | 1644.00 | 1.0195 | 1.0416 | |
| SK-BR-3 | 0 | uM | 9 | 625.00 | 414.82 | 760.00 | 795.25 | 0.9557 | 0.9057 | |
| SK-BR-3 | Erlotinib | 0.01 | uM | 7 | 1250.00 | 859.67 | 1705.00 | 1644.00 | 1.0371 | 1.0794 |
| SK-BR-3 | Erlotinib | 0.1 | uM | 9 | 1250.00 | 830.55 | 1970.00 | 1955.00 | 1.0077 | 1.0124 |
| SK-BR-3 | 17-AAG | 0.0016596 | uM | 7 | 312.50 | 169.63 | 177.00 | 280.00 | 0.6321 | 0.0606 |
| SK-BR-3 | Lapatinib | 0.1 | uM | 9 | 156.25 | 92.36 | 75.00 | 123.25 | 0.6085 | -0.3937 |
| SK-BR-3 | Lapatinib | 0.31623 | uM | 7 | 1250.00 | 859.67 | 1022.00 | 1644.00 | 0.6217 | 0.2031 |
| SK-BR-3 | Lapatinib | 0.0033113 | uM | 9 | 625.00 | 414.82 | 955.00 | 795.25 | 1.2009 | 1.4305 |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 7 | 1250.00 | 859.67 | 819.00 | 1644.00 | 0.4982 | -0.0505 |
| SK-BR-3 | Lapatinib | 0.1 | uM | 9 | 625.00 | 414.82 | 501.00 | 795.25 | 0.6300 | 0.2227 |
| SK-BR-3 | 0 | uM | 7 | 312.50 | 169.63 | 373.00 | 280.00 | 1.3321 | 1.9736 |